- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00534092
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
December 10, 2020 updated by: Medtronic Spine LLC
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
The Long-Term Outcomes Study (LTOS) is a multi-center longitudinal cohort study of all patients who received the X-STOP device in the Pivotal Trial, Continued Access Protocol (CAP), or Cross-over Study (COS).
It is designed to supplement postmarket safety and effectiveness data to be gathered in a Condition of Approval (CoA) study of a population of patients with moderately impaired physical function who elect to undergo X-STOP surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Evaluate the long term safety and effectiveness of the X-Stop interspinous process decompression system In the patients who received the X-Stop under the IDE.
These patients consist of two cohorts to be evaluated: patients who had moderately impaired physical function prior to X-Stop implantation (as determined by a baseline score >2.0 in the physical function (PF) domain of the Zurich claudication questionnaire), and patients who had mildly impaired physical function prior to X-Stop surgery(as determined by a baseline score <=2.0 in the PF domain of the Zurich claudication questionnaire (ZCQ), through the fifth postoperative year.
Clinical examination will be performed at each office visit to confirm the absence of neurological complications.
X-ray films (AP/lateral views) taken during the fifth postoperative year will, be analyzed to confirm A) maintenance of distraction and B) the absence of radiological evidence of device-related complications.
Secondary endpoints will include mean scores from the SF-36, and incidence rates of adverse events, device failures, and secondary surgeries.
Study Type
Observational
Enrollment (Actual)
69
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94117
- St. Mary's Spine Center
-
-
Maine
-
Scarborough, Maine, United States, 04074
- Neurological & Spine Associates
-
-
Maryland
-
Timonium, Maryland, United States, 21093
- Greater Baltimore Spine Care
-
-
Virginia
-
Norfolk, Virginia, United States, 23510
- Neurological Specialist
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who received implants and completed participation in the Pivotal, CAP, or COS studies and has the implant intact and is willing and able to provide consent and return to the clinic for evaluation or complete study questionnaires.
Description
Inclusion Criteria:
A patient will be admitted into the LTOS program if he/she meets all of the following inclusion criteria:
- Completed participation in the Pivotal Trial, CAP, or COS and has the X STOP implant(s) intact at the time of LTOS enrollment; OR is an active CAP/COS participant, has the X STOP implant(s) intact, and has not completed a 24-month follow-up visit in his/her CAP/COS study.
- Is willing and able to provide Informed Consent
- Is willing and able to return to the clinic for a clinical evaluation or complete study questionnaires without a clinic visit.
Exclusion Criteria:
A patient will not be admitted into the LTOS program if he/she meets any of the following exclusion criteria:
- Participated in the Pivotal Trial as part of the X STOP group, but the device has been removed.
- Participated in the CAP or COS programs, but the device has been removed.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Success Rates (At ≥ 5 Years)
Time Frame: 3+ years following first 2 years post-X-STOP implant through IDE study
|
Seven treatment success criteria were defined as follows: clinically significant improvement (at least 0.5 points) in Symptom Severity (SS) domain of Zurich Claudication Questionnaire (ZCQ), clinically significant improvement (at least 0.5 points) in Physical Function (PF) domain of ZCQ, Patient Satisfaction (PS) score of <2.5 points in ZCQ, no additional lumbar spinal stenosis surgery at the index level, maintenance of distraction, no device dislodgement, no device-related complications.
All 7 criteria must be met to be considered a treatment success.
|
3+ years following first 2 years post-X-STOP implant through IDE study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Symptom Severity (SS) and Physical Functioning (PF) as Using Zurich Claudication Questionnaire (ZCQ) Domain Scores (At ≥ 5 Years)
Time Frame: Baseline and 3+ years following first 2 years post-X-STOP implant through IDE study
|
ZCQ is a validated outcomes instrument specific to lumbar spinal stenosis, and captures data in 3 distinct domains: SS, PF, and post-treatment Patient Satisfaction (PS).
SS domain is based on seven questions (overall pain, pain frequency, pain in the back, pain in the leg, numbness, weakness, and balanced disturbance).
The first 6 questions are scored 1 to 5. Balance disturbance is scored in a 1-3-5 scale.
The SS score is the mean of all answered items in the questionnaire ranging from 1to 5.
If more than two items were missing, the SS score was considered as missing.
PF score is the mean of five physical function questions ranging from 1 to 4. If more than one item were missing, the PF score was considered as missing.
In each domain, a lower score represents a better outcome/condition.
The change is calculated as the score at 5+ years after X-STOP implantation minus the baseline score.
|
Baseline and 3+ years following first 2 years post-X-STOP implant through IDE study
|
Patient Satisfaction (PS) as Assessed by Zurich Claudication Questionnaire (ZCQ) Domain Scores (At ≥ 5 Years)
Time Frame: 3+ years following first 2 years post-X-STOP implant through IDE study
|
ZCQ is a validated outcomes instrument specific to lumbar spinal stenosis, and captures data in 3 distinct domains: SS, PF, and post-treatment Patient Satisfaction (PS).
PS score is the mean of 6 questions scored from 1 to 4 if the number of responses exceeded four, a lower score represents a better outcome.
Patients with mean scores <2.5 at 5 years postoperative evaluation were considered positive, which implied patient treatment satisfaction.
|
3+ years following first 2 years post-X-STOP implant through IDE study
|
Change in Quality of Life Using Short Form 36-Question (SF-36) Health Survey (At ≥ 5 Years)
Time Frame: Baseline and 3+ years following first 2 years post-X-STOP implant through IDE study
|
Quality of life was assessed by the SF-36 health survey.
It includes 8 subdomains (bodily pain, physical functioning, role-physical, general health and vitality, social functioning, role-emotional, and mental health) and 2 component summaries (physical component summary [PCS] and mental component summary [MCS]).
Scores for each subdomain and component summary range from 0 "worst" to 100 "best.
The change from baseline to the 5 year postoperative visit for each of these domains is presented.
|
Baseline and 3+ years following first 2 years post-X-STOP implant through IDE study
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients With Subsequent Lumbar Spinal Surgeries That Occurred During the Study
Time Frame: 3+ years following first 2 years post-X-STOP implant through IDE study
|
The surgeries that occurred subsequent to the original X-STOP implantation were categorized as revision, removal, reoperation, supplemental fixation, and other.
|
3+ years following first 2 years post-X-STOP implant through IDE study
|
Number of Patients With Device/Procedure Related Adverse Events That Occurred During the Study
Time Frame: 3+ years following first 2 years post-X-STOP implant through IDE study
|
3+ years following first 2 years post-X-STOP implant through IDE study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zucherman JF, Hsu KY, Hartjen CA, Mehalic TF, Implicito DA, Martin MJ, Johnson DR 2nd, Skidmore GA, Vessa PP, Dwyer JW, Puccio ST, Cauthen JC, Ozuna RM. A multicenter, prospective, randomized trial evaluating the X STOP interspinous process decompression system for the treatment of neurogenic intermittent claudication: two-year follow-up results. Spine (Phila Pa 1976). 2005 Jun 15;30(12):1351-8. doi: 10.1097/01.brs.0000166618.42749.d1.
- Hsu KY, Zucherman JF, Hartjen CA, Mehalic TF, Implicito DA, Martin MJ, Johnson DR 2nd, Skidmore GA, Vessa PP, Dwyer JW, Cauthen JC, Ozuna RM. Quality of life of lumbar stenosis-treated patients in whom the X STOP interspinous device was implanted. J Neurosurg Spine. 2006 Dec;5(6):500-7. doi: 10.3171/spi.2006.5.6.500.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2006
Study Completion (Actual)
June 1, 2010
Study Registration Dates
First Submitted
September 20, 2007
First Submitted That Met QC Criteria
September 21, 2007
First Posted (Estimate)
September 24, 2007
Study Record Updates
Last Update Posted (Actual)
January 5, 2021
Last Update Submitted That Met QC Criteria
December 10, 2020
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LSS-004-LTO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Spinal Stenosis
-
Johns Hopkins UniversityNorth American Spine SocietyCompletedLumbar Spinal Stenosis | Lumbar Spine Degeneration | Lumbar Spinal InstabilityUnited States
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
Medipol UniversityWithdrawnLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine Degeneration | Lumbar Spine InstabilityTurkey
-
University Hospital, Basel, SwitzerlandKlinik für Radiologie und Nuklearmedizin, University Hospital BaselCompletedLumbar Spinal Stenosis | Symptomatic Lumbar Spinal StenosisSwitzerland
-
Bursa City HospitalCompletedLumbar Spinal Stenosis | Lumbar Spine Degeneration | Lumbar Spine InstabilityTurkey
-
Xuanwu Hospital, BeijingRecruitingLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar SpondylosisChina
-
Neurocenter of Southern SwitzerlandMaastricht University; Schulthess KlinikRecruitingLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Spinal Disease | Lumbar InstabilitySwitzerland
-
University of Roma La SapienzaRecruitingLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Spine Degeneration | Lumbar Spine InstabilityItaly
-
Cantonal Hospital of St. GallenProf. Dr. Astrid Weyerbrock, Klinik für Neurochirurgie, Kantonsspital St.... and other collaboratorsCompletedLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine DegenerationSwitzerland
-
Kyungpook National University HospitalCompletedDisk Herniated Lumbar | Spinal Stenosis LumbarKorea, Republic of
Clinical Trials on X STOP® Interspinous Process Decompression System
-
Norwegian University of Science and TechnologyTerminatedRadiculopathy | Lumbar Spinal StenosisNorway
-
Boston Scientific CorporationVertiFlex, IncorporatedCompletedIntermittent Claudication | Lumbar Spinal StenosisUnited States
-
Medtronic Spine LLCWithdrawnLumbar Spinal Stenosis
-
Zimmer SpineZimmer BiometUnknown
-
Boston Scientific CorporationCompletedLumbar Spinal StenosisUnited States
-
Baxano Surgical, Inc.UnknownRadiculopathy | Lumbar Spinal Stenosis | SpondylolisthesisUnited States
-
Erasme University HospitalUniversity of Liege; Bone Therapeutics S.ACompletedAvascular Necrosis of Femur HeadBelgium
-
Bone Therapeutics S.ATerminatedStudy on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral HeadOsteonecrosis of the Femoral Head
-
Children's Hospital of PhiladelphiaCompletedPain | AnxietyUnited States